graft versus host disease in a patient with chronic granulocytic leukemia who received an hematopoietic progenitor cell transplant
Clicks: 167
ID: 242331
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
167 views
28 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #16 of 36 articles by views in trac trends in analytical chemistry
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Male patient age 6 years 9 months, native of the State of Mexico,
without relevant antecedents. Parents age 32 years, with highschool
level education, merchants; subject has a brother age 10
years and a sister age 4 years. His government vaccination plan
is complete. Two months ago he presented onset of fever, epistaxis,
and splenomegaly. At Hospital Materno Infantil de Toluca
the blood biometry reported: hemoglobin 8.8 g/dL, hematocrit
24%, leukocytes 230,500/mm3, neutrophils 21%, bands 34%,
lymphocytes 9%, monocytes 7%, blasts 14%, basophils 11%,
eosinophils 4%. An analysis found: serum creatinine and liver
function tests normal.
| Reference Key |
zapata-tarrs2014actagraft
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Marta Zapata-Tarrés;Eduardo López-Corella;Martín Pérez-García;Roberto Rivera-Luna |
| Journal | trac trends in analytical chemistry |
| Year | 2014 |
| DOI |
10.18233/APM35No1pp39-47
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.